First EMEA meeting of Committee for Advanced Therapies.(Regulatory Action and News)(Report)

European Union -- On 15 and 16 January, the European Medicines Agency (EMEA) held its first meeting of the new Committee for Advanced Therapies (CAT). The CAT is a multidisciplinary committee, gathering together some of the best available experts in Europe to assess the quality, safety and efficacy of advanced therapy medicinal products (ATMPs) and to follow scientific developments in the field.

ATMPs are medicinal products for human use based on gene therapy, somatic cell therapy or tissue engineering. They may offer groundbreaking new treatment opportunities for diseases and injuries of the human body. The regulatory framework established by the new legislation on ATMPs is …